Production (Stage)
LAVA Therapeutics N.V.
LVTX
$1.32
$0.021.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.08% | -2.93% | -9.12% | -8.22% | -1.04% |
| Total Receivables | -- | -- | -10.87% | 26.79% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 45.62% | -34.19% | -26.72% | 87.12% | -26.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.79% | -- | -- | -- | -- |
| Total Current Assets | -12.00% | -2.75% | -9.58% | -6.72% | -2.25% |
|
|
|||||
| Total Current Assets | -12.00% | -2.75% | -9.58% | -6.72% | -2.25% |
| Net Property, Plant & Equipment | -11.23% | -15.37% | -13.32% | -8.72% | -12.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.40% | -20.18% | -20.83% | -43.75% | -19.75% |
| Total Assets | -11.97% | -3.03% | -9.67% | -6.86% | -2.55% |
|
|
|||||
| Total Accounts Payable | -44.16% | -3.30% | -32.35% | 21.06% | -22.69% |
| Total Accrued Expenses | -24.68% | 45.93% | 53.33% | 6.16% | -10.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -94.12% | -15.10% | 4.40% | 2.14% | 0.84% |
| Total Finance Division Other Current Liabilities | 74.92% | -- | -- | -- | -- |
| Total Other Current Liabilities | 74.92% | -- | -- | -- | -- |
| Total Current Liabilities | -42.43% | 18.46% | 7.72% | 8.32% | -12.54% |
|
|
|||||
| Total Current Liabilities | -42.43% | 18.46% | 7.72% | 8.32% | -12.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -92.50% | -51.22% | -44.41% | -23.77% | -6.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -14.53% | 5.40% | 1.94% | 2.05% | -3.77% |
|
|
|||||
| Common Stock & APIC | 0.25% | 8.68% | 0.00% | 0.01% | -6.59% |
| Retained Earnings | -1.99% | -3.58% | -7.79% | -5.55% | 0.92% |
| Treasury Stock & Other | 7.73% | -436.84% | 161.27% | 44.23% | 109.15% |
| Total Common Equity | -7.07% | -15.91% | -23.05% | -15.37% | -1.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.07% | -15.91% | -23.05% | -15.37% | -1.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.07% | -15.91% | -23.05% | -15.37% | -1.36% |
|
|
|||||